Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 46

1.

Novel Hyaluronic Acid Conjugates for Dual Nuclear Imaging and Therapy in CD44-Expressing Tumors in Mice In Vivo.

Dubey RD, Klippstein R, Wang JT, Hodgins N, Mei KC, Sosabowski J, Hider RC, Abbate V, Gupta PN, Al-Jamal KT.

Nanotheranostics. 2017 Jan 1;1(1):59-79. doi: 10.7150/ntno.17896. eCollection 2017.

2.

Cardioprotective effects of Cu(II)ATSM in human vascular smooth muscle cells and cardiomyocytes mediated by Nrf2 and DJ-1.

Srivastava S, Blower PJ, Aubdool AA, Hider RC, Mann GE, Siow RC.

Sci Rep. 2016 Dec 21;6(1):7. doi: 10.1038/s41598-016-0012-5.

3.

Hydroxypyridinone Chelators: From Iron Scavenging to Radiopharmaceuticals for PET Imaging with Gallium-68.

Cusnir R, Imberti C, Hider RC, Blower PJ, Ma MT.

Int J Mol Sci. 2017 Jan 8;18(1). pii: E116. doi: 10.3390/ijms18010116. Review.

4.

A Powerful Mitochondria-Targeted Iron Chelator Affords High Photoprotection against Solar Ultraviolet A Radiation.

Reelfs O, Abbate V, Hider RC, Pourzand C.

J Invest Dermatol. 2016 Aug;136(8):1692-700. doi: 10.1016/j.jid.2016.03.041. Epub 2016 Apr 22.

5.

Copper(II) binding properties of hepcidin.

Kulprachakarn K, Chen YL, Kong X, Arno MC, Hider RC, Srichairatanakool S, Bansal SS.

J Biol Inorg Chem. 2016 Jun;21(3):329-38. doi: 10.1007/s00775-016-1342-2. Epub 2016 Feb 16.

6.

Targeted redox inhibition of protein phosphatase 1 by Nox4 regulates eIF2α-mediated stress signaling.

Santos CX, Hafstad AD, Beretta M, Zhang M, Molenaar C, Kopec J, Fotinou D, Murray TV, Cobb AM, Martin D, Zeh Silva M, Anilkumar N, Schröder K, Shanahan CM, Brewer AC, Brandes RP, Blanc E, Parsons M, Belousov V, Cammack R, Hider RC, Steiner RA, Shah AM.

EMBO J. 2016 Feb 1;35(3):319-34. doi: 10.15252/embj.201592394. Epub 2016 Jan 7.

7.
8.

Second international round robin for the quantification of serum non-transferrin-bound iron and labile plasma iron in patients with iron-overload disorders.

de Swart L, Hendriks JC, van der Vorm LN, Cabantchik ZI, Evans PJ, Hod EA, Brittenham GM, Furman Y, Wojczyk B, Janssen MC, Porter JB, Mattijssen VE, Biemond BJ, MacKenzie MA, Origa R, Galanello R, Hider RC, Swinkels DW.

Haematologica. 2016 Jan;101(1):38-45. doi: 10.3324/haematol.2015.133983. Epub 2015 Sep 18.

9.

Synthesis of double-clickable functionalised graphene oxide for biological applications.

Mei KC, Rubio N, Costa PM, Kafa H, Abbate V, Festy F, Bansal SS, Hider RC, Al-Jamal KT.

Chem Commun (Camb). 2015 Oct 18;51(81):14981-4. doi: 10.1039/c5cc05412e.

10.

Iron Deficiency Impairs Intra-Hepatic Lymphocyte Mediated Immune Response.

Bonaccorsi-Riani E, Danger R, Lozano JJ, Martinez-Picola M, Kodela E, Mas-Malavila R, Bruguera M, Collins HL, Hider RC, Martinez-Llordella M, Sanchez-Fueyo A.

PLoS One. 2015 Aug 19;10(8):e0136106. doi: 10.1371/journal.pone.0136106. eCollection 2015.

11.

Solvent-Free Click-Mechanochemistry for the Preparation of Cancer Cell Targeting Graphene Oxide.

Rubio N, Mei KC, Klippstein R, Costa PM, Hodgins N, Wang JT, Festy F, Abbate V, Hider RC, Chan KL, Al-Jamal KT.

ACS Appl Mater Interfaces. 2015 Sep 2;7(34):18920-3. doi: 10.1021/acsami.5b06250. Epub 2015 Aug 20.

12.

Organic Solvent-Free, One-Step Engineering of Graphene-Based Magnetic-Responsive Hybrids Using Design of Experiment-Driven Mechanochemistry.

Mei KC, Guo Y, Bai J, Costa PM, Kafa H, Protti A, Hider RC, Al-Jamal KT.

ACS Appl Mater Interfaces. 2015 Jul 8;7(26):14176-81. doi: 10.1021/acsami.5b03577. Epub 2015 Jun 25.

13.

Tripodal tris(hydroxypyridinone) ligands for immunoconjugate PET imaging with (89)Zr(4+): comparison with desferrioxamine-B.

Ma MT, Meszaros LK, Paterson BM, Berry DJ, Cooper MS, Ma Y, Hider RC, Blower PJ.

Dalton Trans. 2015 Mar 21;44(11):4884-900. doi: 10.1039/c4dt02978j.

14.

Iron-chelating and anti-lipid peroxidation properties of 1-(N-acetyl-6-aminohexyl)-3-hydroxy-2-methylpyridin-4-one (CM1) in long-term iron loading β-thalassemic mice.

Kulprachakarn K, Chansiw N, Pangjit K, Phisalaphong C, Fucharoen S, Hider RC, Santitherakul S, Srichairatanakool S.

Asian Pac J Trop Biomed. 2014 Aug;4(8):663-8. doi: 10.12980/APJTB.4.2014APJTB-2014-0155.

15.

Non-transferrin-bound iron (NTBI) uptake by T lymphocytes: evidence for the selective acquisition of oligomeric ferric citrate species.

Arezes J, Costa M, Vieira I, Dias V, Kong XL, Fernandes R, Vos M, Carlsson A, Rikers Y, Porto G, Rangel M, Hider RC, Pinto JP.

PLoS One. 2013 Nov 21;8(11):e79870. doi: 10.1371/journal.pone.0079870. eCollection 2013.

16.

Feruloyl-CoA 6'-Hydroxylase1-dependent coumarins mediate iron acquisition from alkaline substrates in Arabidopsis.

Schmid NB, Giehl RF, Döll S, Mock HP, Strehmel N, Scheel D, Kong X, Hider RC, von Wirén N.

Plant Physiol. 2014 Jan;164(1):160-72. doi: 10.1104/pp.113.228544. Epub 2013 Nov 18.

17.

Structural analysis of cytochrome P450 105N1 involved in the biosynthesis of the zincophore, coelibactin.

Zhao B, Moody SC, Hider RC, Lei L, Kelly SL, Waterman MR, Lamb DC.

Int J Mol Sci. 2012;13(7):8500-13. doi: 10.3390/ijms13078500. Epub 2012 Jun 1.

18.

Iron requirements based upon iron absorption tests are poorly predicted by haematological indices in patients with inactive inflammatory bowel disease.

Lomer MC, Cook WB, Jan-Mohamed HJ, Hutchinson C, Liu DY, Hider RC, Powell JJ.

Br J Nutr. 2012 Jun;107(12):1806-11. doi: 10.1017/S0007114511004971. Epub 2011 Dec 9.

19.

Efficient bifunctional gallium-68 chelators for positron emission tomography: tris(hydroxypyridinone) ligands.

Berry DJ, Ma Y, Ballinger JR, Tavaré R, Koers A, Sunassee K, Zhou T, Nawaz S, Mullen GE, Hider RC, Blower PJ.

Chem Commun (Camb). 2011 Jul 7;47(25):7068-70. doi: 10.1039/c1cc12123e. Epub 2011 May 27.

20.

Mechanisms for the shuttling of plasma non-transferrin-bound iron (NTBI) onto deferoxamine by deferiprone.

Evans P, Kayyali R, Hider RC, Eccleston J, Porter JB.

Transl Res. 2010 Aug;156(2):55-67. doi: 10.1016/j.trsl.2010.05.002. Epub 2010 May 27.

Supplemental Content

Loading ...
Support Center